Impact of Community Treatment With Ivermectin for the Control of Scabies on the Prevalence of Antibodies to Strongyloides stercoralis in Children.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 32421762.
- Also identified by DOI 10.1093/cid/ciaa584 and PMC identifier 7819519.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The prevalence of antibodies to Strongyloides stercoralis was measured in 0-12-year-olds using a bead-based immunoassay before and after ivermectin mass drug administration (MDA) for scabies in the Solomon Islands. Seroprevalence was 9.3% before and 5.1% after MDA (P = .019), demonstrating collateral benefits of ivermectin MDA in this setting.
Medical subject headings
- Scabies
- Strongyloides stercoralis
- Strongyloidiasis